• 12 Hits
  • Search Condition : Filter (MeSH = Head and Neck Neoplasms / drug therapy)
Species Resource Title
Human and Animal Cells A431(RCB0202) Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.
Human and Animal Cells KP4(RCB1005) , EBC-1(RCB1965) Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models.
Human and Animal Cells HTC/C3(RCB0452) CD40 stimulation inhibits cell growth and Fas-mediated apoptosis in a thyroid cancer cell line.
Human and Animal Cells HSC-2(RCB1945) , HSC-4(RCB1902) Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
Human and Animal Cells Ca9-22(RCB1976) , HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) Quantitative Structure-Cytotoxicity Relationship of Cinnamic Acid Phenetyl Esters.
Human and Animal Cells HSC-3(RCB1975) , HSC-4(RCB1902) , Sa-3(RCB0980) Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor.
Human and Animal Cells Ca9-22(RCB1976) , HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) Quantitative structure-cytotoxicity relationship of phenylpropanoid amides.
Human and Animal Cells Ho-1-u-1(RCB2102) , HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Sa3(RCB0980) EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma.
Human and Animal Cells HL60(RCB0041) Cytotoxicity and type of cell death induced by local anesthetics in human oral normal and tumor cells.
Human and Animal Cells HSQ-89(RCB0789) A cDNA microarray analysis identifies 52 genes associated with cis-diamminedichloroplatinum susceptibility in head and neck squamous cell carcinoma cell lines.